Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Schwerin – page 4

95 clinical trials in Schwerin, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Schwerin at a glance
95
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

95 trials in Schwerin

Open in trial search

Arteriosclerosis

Not yet recruiting

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Muvalaplin
  • Sponsor:Eli Lilly & Co.

Metapneumovirus infection

Not yet recruiting

Study on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:IVX-121
  • Sponsor:AstraZeneca AB

Conjunctivitis allergic

Not yet recruiting

Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Allergy Therapeutics (UK) Limited

Narcolepsy

Not yet recruiting

A Randomized, Double‑Blind Study of ORX750 versus Placebo for Excessive Daytime Sleepiness in Adults with Narcolepsy (Type 1 and Type 2)

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ORX750
  • Sponsor:Centessa Pharmaceuticals UK Limited

Influenza

Not yet recruiting

A Phase 3 Study of Efitazanamivir Alfa for Preventing Influenza in Adults and Adolescents at High Risk of Complications

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Cidara Therapeutics Inc.

Acute lymphocytic leukaemia

Not yet recruiting

Study of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Asparaginase
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Alumis Inc.

Hypercholesterolaemia

Not recruiting

Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Migraine

Not recruiting

Study of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Psoriasis

Not recruiting

Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Envudeucitinib
  • Sponsor:Alumis Inc.

Diabetic neuropathy

Not recruiting

Study on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cannabis Sativa Flower
  • Sponsor:Syqe Medical Ltd.

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Schwerin

What the registry says about research in the country

01 Respiratory and Viral Research

Studies focusing on respiratory infections including trials evaluating vaccines against RSV and human metapneumovirus. Additional research examines improved influenza protection in adults over 50 years with stable comorbidities.

  • RSV and hMPV Prevention
  • Influenza Vaccination
  • Immunogenicity Studies
02 Dermatology Studies

Multiple investigations into treatments for plaque psoriasis, with emphasis on evaluating new therapeutic options for moderate to severe cases. Research includes long-term safety assessments and comparative efficacy studies.

  • Moderate to Severe Psoriasis
  • Novel Treatment Evaluation
  • Long-term Safety Studies
03 Oncology Research

Comprehensive cancer studies including breast cancer, colon cancer, and lymphoma treatments. Trials evaluate pre-operative therapies, immunotherapy combinations, and specialized protocols for pediatric patients.

  • Triple-Negative Breast Cancer
  • Colon Cancer Treatment
  • B-cell Lymphoma Therapies
04 Neurological Disorders

Research focusing on Alzheimer's Disease, migraine prevention, and neurological conditions. Studies evaluate new therapeutic approaches and compare treatment efficacy with existing medications.

  • Early Alzheimer's Treatment
  • Migraine Prevention
  • Inflammatory Biomarkers
05 Mental Health Studies

Extensive research into Major Depressive Disorder and ADHD, investigating new therapeutic approaches and long-term treatment outcomes. Studies include both adult and adolescent populations.

  • Depression Treatment
  • ADHD Management
  • Long-term Safety Assessments
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.